\n Webcast replay <\/p>\n <\/div>\n
\n <\/p>\n
Une conf\u00e9rence t\u00e9l\u00e9phonique et un webcast destin\u00e9s aux investisseurs et analystes se tiendront ont eu lieu le 26 octobre 2023. Un enregistrement est disponible ci-dessous.<\/p>\n \n Webcast replay \n <\/a>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n <\/div>\n<\/section>\n\n\n\n\n\n <\/p>\n \n David Loew <\/p>\n \n \n Directeur G\u00e9n\u00e9ral <\/span>\n <\/p>\n \n <\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/a>\n \n\n <\/div>\n\n <\/div>\n <\/div>\n \n Aymeric Le Chatelier <\/p>\n \n \n Vice-Pr\u00e9sident Ex\u00e9cutif <\/span>\n <\/p>\n \n Directeur Financier <\/p>\n <\/div>\n <\/div>\n <\/div>\n <\/a>\n \n\n <\/div>\n\n <\/div>\n <\/div>\n \n <\/div>\n <\/div>\n <\/div>\n<\/div> <\/section>\n <\/div>\n\n\n\n\n Ipsen<\/strong><\/p>\n\n\n\n Ipsen est une soci\u00e9t\u00e9 biopharmaceutique mondiale de taille moyenne focalis\u00e9e sur la mise au point de m\u00e9dicaments innovants en Oncologie, dans les Maladies Rares et en Neurosciences. Avec un chiffre d\u2019affaires Groupe de 3,0 milliards d\u2019euros pour l\u2019exercice 2022, Ipsen vend des m\u00e9dicaments dans plus de 100 pays. Outre sa strat\u00e9gie d\u2019innovation externe, les efforts d\u2019Ipsen en mati\u00e8re de R&D sont focalis\u00e9s sur ses plateformes technologiques diff\u00e9renci\u00e9es et innovantes situ\u00e9es au c\u0153ur de clusters mondiaux de la recherche biotechnologique ou en sciences de la vie : Paris-Saclay, France ; Oxford, Royaume-Uni ; Cambridge, \u00c9tats-Unis ; Shanghai, Chine. Ipsen emploie environ 5 300 collaborateurs dans le monde. Ipsen est cot\u00e9 \u00e0 Paris (Euronext : IPN) et aux \u00c9tats-Unis \u00e0 travers un programme d\u2019American Depositary Receipt (ADR : IPSEY) sponsoris\u00e9 de niveau I. Le site Internet d\u2019Ipsen est ipsen.com<\/a>.<\/p>\n\n\n\n Contacts<\/strong> <\/strong><\/p>\n\n\n\n Investors<\/u><\/strong><\/p>\n\n\n\n Craig Marks<\/strong>, Vice President, Investor Relations, +44 (0)7584 349 193 Media<\/u><\/strong><\/p>\n\n\n\n Amy Wolf<\/strong>, Vice President and Head of Corporate Brand Strategy and Communications, +41 79 576 07 23 Ipsen a publi\u00e9 son chiffre d\u2019affaires r\u00e9alis\u00e9 depuis le d\u00e9but de l\u2019ann\u00e9e et du troisi\u00e8me trimestre le 26 octobre 2023<\/p>\n","protected":false},"author":11,"featured_media":19144,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[3521,1215,3515],"tags":[],"class_list":["post-40527","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-ytd-sales-fr","category-general-fr","category-financial-results-fr","entry"],"acf":[],"yoast_head":"\nPr\u00e9sentateurs<\/h2>\n
Nicolas Bogler<\/strong>, Senior Investor Relations Manager, +33 6 52 19 98 92 <\/p>\n\n\n\n
Ioana Piscociu<\/strong>, Senior Manager, Global Media Relations, +33 6 69 09 12 96<\/p>\n","protected":false},"excerpt":{"rendered":"